Global Public Health (journal)

IQVIA and CEPI Collaborate to Strengthen Global Research Preparedness to Advance the 100 Days Mission

Retrieved on: 
Wednesday, October 11, 2023
COVID-19, Infectious Diseases, Clinical Trials, Health Technology, Other Health, Biotechnology, Pharmaceutical, Health, Science, Other Science, Disease, Infection, NYSE, Global Public Health (journal), Research, Vaccine, IQV, Surge (drink), CEPI, Pandemic, G7, G20, Developing country, Epidemic, Low, Coalition for Epidemic Preparedness Innovations, Coalition, Patient, Pharmaceutical industry, IQVIA

IQVIA, (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services, and The Coalition for Epidemic Preparedness Innovations (CEPI) today announced a strategic collaboration to advance the 100 Days Mission.

Key Points: 
  • IQVIA, (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services, and The Coalition for Epidemic Preparedness Innovations (CEPI) today announced a strategic collaboration to advance the 100 Days Mission.
  • In conjunction with national and regional collaborators, CEPI and IQVIA will aim to enhance the world’s preparedness to rapidly conduct life-saving clinical research for vaccines and other biological countermeasures against emerging infectious diseases.
  • This clinical research preparedness has been identified as a key enabler of the 100 Days Mission : a goal spearheaded by CEPI, and backed by the G7 and G20, which aims to accelerate the time taken to develop safe, effective, globally accessible vaccines against emerging disease outbreaks to within 100 days.
  • IQVIA’s collaboration with CEPI will support the 100 Days Mission in delivering transformative healthcare worldwide.

Backsliding on COVID Data is a Global Health Threat, Says AHF

Retrieved on: 
Monday, August 28, 2023
COVID-19, Infectious Diseases, Advocacy Group Opinion, Public Policy, Government, Other Health, AIDS, General Health, Health, Other Policy Issues, AHF, Global Public Health (journal), United Nations, Health policy, HIV, Public, Negotiation, COVID-19 deaths, Intensive care medicine, Death, Pandemic, Patient, AIDS Healthcare Foundation, WHO, Intensive care unit, World Health Organization, Pharmaceutical industry

“Without timely and reliable data, we could be flying blind into a new, deadly strain of COVID-19, and we wouldn’t even know it.

Key Points: 
  • “Without timely and reliable data, we could be flying blind into a new, deadly strain of COVID-19, and we wouldn’t even know it.
  • Parties involved in negotiating the Global Public Health Agreement must exert maximum effort to ensure data sharing and transparency become a fundamental part of the new pandemic accord,” said AHF President Michael Weinstein.
  • The global response to HIV has long been hampered by poor data reporting.
  • To prevent and effectively fight pandemics and outbreaks, frontline responders must have reliable and timely data – it is of utmost importance to global public health security.”

IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening

Retrieved on: 
Thursday, May 25, 2023
Health Technology, Data Management, Technology, Pharmaceutical, Philanthropy, Fund Raising, Clinical Trials, Foundation, Science, Biotechnology, Software, AIDS, Other Science, Health, Research, Tuberculosis, Executive, Rockefeller Foundation, Global Public Health (journal), Partnership, Asylum, Migration and Integration Fund, The Global Fund to Fight AIDS, Tuberculosis and Malaria, IQVIA, Abbott, COVID-19, Infection, Global health, Mark R. Dybul, Pandemic, Investment, Laboratory, Bono, Bill, IQV, Diagnosis, Bill & Melinda Gates Foundation, Fund, Family, NYSE, RED, Pharmaceutical industry, Vaccine, Malaria

IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today with (RED), the organization co-founded by Bono and Bobby Shriver to fight AIDS and the injustices that enable pandemics to thrive, to support laboratory system strengthening and save lives.

Key Points: 
  • IQVIA ™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life science industry, announced a groundbreaking partnership today with (RED), the organization co-founded by Bono and Bobby Shriver to fight AIDS and the injustices that enable pandemics to thrive, to support laboratory system strengthening and save lives.
  • The $5 million impact partnership will channel life-saving money to the Global Fund’s Laboratory Systems Integration Fund.
  • Doubling the impact, the Bill & Melinda Gates Foundation will match every dollar from the partnership to the Global Fund.
  • “Every day, IQVIA works alongside our customers and partners to help improve global health.

Scrub In & Rock Out: Surgeons Preview Highway to Heal Album and World's First AI Healthcare Radio Station at NextMed Health

Retrieved on: 
Tuesday, March 14, 2023
Technology, Surgery, Hospitals, Entertainment, Audio, Video, TV and Radio, Health, Music, Artificial Intelligence, Gesture, Research, AI, Movement, SPF, Radio, Global Public Health (journal), Hand, Artificiality, DJ, Name, OR, Data science, Fungus, Patient, Multimedia, United States National Library of Medicine, Medicine, AC/DC, Artificial intelligence, Human back, National library, Melanoma, It's a Long Way to the Top (If You Wanna Rock 'n' Roll), Medical device, Dentistry, Nursing, Politics

View the full release here: https://www.businesswire.com/news/home/20230313005235/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230313005235/en/
    NextMed Health today debuted Highway to Heal, the AC/DC-inspired album clinically designed to help surgical teams increase accuracy and efficiency.
  • The music will launch in April on Lifesaving Radio, the world's first AI-powered healthcare radio station–complete with an AI DJ to personalize the listening experience.
  • (Photo: Business Wire)
    “We are excited to bring Highway to Heal and Lifesaving Radio to the medical community–rockstars in their own right,” said NextMed Health Founder & Chair Daniel Kraft, M.D.
  • Curated playlists will include music from Highway to Heal and other rock classics similar in beat and tempo.

FINN Partners and Hyderus Unite to Create Major Global Health Communications and Policy Practice Serving Multinational Pharmaceutical, Vaccine, Device and Diagnostic Companies

Retrieved on: 
Tuesday, February 14, 2023
Well, Chantal, Bill, Agency, Global Public Health (journal), London School of Hygiene and Tropical Medicine, Drug development, Consultant, Health policy, Lazar, CMC, Patient, Infection, Tropical medicine, SPAG, Bill & Melinda Gates Foundation, Research, Policy, Marketing, Partnership, Notifiable disease, Growth, COVID, Public, Communication, Vaccine hesitancy, Management, Pharmaceutical industry, Hygiene, EU

DUBLIN, LONDON and NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Global independent marketing and communications agency FINN Partners announced today that Hyderus, a leading international, health-focused communications and policy firm, joins FINN. With a network in Europe, Africa, Asia and Latin America, Hyderus provides expert guidance on a range of vital health policy issues to leading biopharma companies and non-governmental organizations. Co-founders Mark Chataway and Christopher Nial join FINN and take leadership positions in the Agency's Global Health Practice and will co-lead its EMEA Public Health Group. Both will report to Gil Bashe, Chair Global Health and Purpose.

Key Points: 
  • Co-founders Mark Chataway and Christopher Nial join FINN and take leadership positions in the Agency's Global Health Practice and will co-lead its EMEA Public Health Group.
  • Both Chataway and Nial become EMEA Public Health leads in the Global Health Practice, as well as members of the agency's Global Health Practice leadership team, which Lazar facilitates.
  • Well-known for its global work in public health, health policy strategy, drug development and marketing communications, risk perception and crisis management, Hyderus will now be branded "Hyderus, a FINN Partners Company."
  • With more than $50 million in revenues, the FINN Global Health Practice is now ranked among the world's largest independent health practices.

Cure® Names Seema Kumar Chief Executive Officer

Retrieved on: 
Wednesday, October 5, 2022
Therapy, Government, Project, Road, Laboratory, Skolkovo Innovation Center, Organization, Johnson & Johnson, World Economic Forum, Whitehead Institute, Research, Company, Dream, Technology, Davos, Park Avenue, Industry, Health, Global Public Health (journal), Broad Institute, Founder, CEO, MIT, Human, Lecture, Global Health, Human Genome Project, COVID-19, Engineering, Pharmaceutical industry, Cure

NEW YORK, Oct. 5, 2022 /PRNewswire/ --Cure, a healthcare innovation campus in New York City, announced today that Seema Kumar has been named Chief Executive Officer (CEO).

Key Points: 
  • NEW YORK, Oct. 5, 2022 /PRNewswire/ --Cure, a healthcare innovation campus in New York City, announced today that Seema Kumar has been named Chief Executive Officer (CEO).
  • Ms. Kumar joins Cure today from Johnson & Johnson where she spent nearly 20 years in senior leadership positions, most recently serving as Global Head of the Office of Innovation, Global Health and Scientific Engagement.
  • Prior to that she was Chief of Staff and Chief Communications Officer at MIT's Whitehead Institute, playing a leading role in the Human Genome Project and the creation and launch of the Broad Institute.
  • "I am thrilled and excited to be joining Cure as its CEO and lead the mission to help transform and advance healthcare by continuing to build an active healthcare network and diverse community," said Seema Kumar, Chief Executive Officer of Cure.

ForSight Robotics Raises $55 Million in Series A Round to Develop World's First Fully Robotic Cataract Surgery Procedure

Retrieved on: 
Wednesday, July 20, 2022
Eclipse, Mithril, AI, Group, Surgeon, Development, Environment, Defense, JAMA Ophthalmology, Airport, Goodness, Flex (company), Industry, Adani Group, Real estate, Adani, Mechanics, Solution, Software, Eye, Growth, Cataract, Severe cognitive impairment, Apple, Israel Innovation Authority, Robotics, Machine learning, Renewable energy, GE, Intuitive Surgical, Technology, Tesla, Global Public Health (journal), Patient, Quintet Private Bank, Retina, Nation-building, Health, Glaucoma, CSR, Mazor Robotics, Self-help group (finance), Saṃsāra, Intel, 3D printing, Veterinary medicine, Health insurance, Medical device, Management, Ophthalmology, Resource

YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- ForSight Robotics, the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world's first surgical platform for fully robotic cataract surgery: ORYOM. ForSight's flagship robotic platform will increase accessibility to ophthalmic surgery procedures worldwide and ultimately, transform the future of eye surgery.

Key Points: 
  • YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- ForSight Robotics , the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world's first surgical platform for fully robotic cataract surgery: ORYOM .
  • ForSight's flagship robotic platform will increase accessibility to ophthalmic surgery procedures worldwide and ultimately, transform the future of eye surgery.
  • Following an initial $10 million mega-seed round last year, ForSight has advanced its technological capabilities and doubled in size.
  • ForSight's first procedure is cataract surgery, the most common surgical procedure with approximately 28M procedures worldwide per year.

Kaiser Permanente Bernard J. Tyson School of Medicine Announces New Assistant Dean for Community Engagement

Retrieved on: 
Monday, August 30, 2021
University, Kaiser Permanente Bernard J. Tyson School of Medicine, Global Public Health (journal), Clinical research, North Carolina, Community, Clinical and Translational Science Award, CTSA, Knowledge, Physician, Biomedical sciences, Research, Government, Health, Curriculum, Behavior, National, MPH, Texas Department of Housing and Community Affairs, Student, Public health, Lori, Education, Academy, Kaiser, Health equity, Public relations, Management

PASADENA, Calif., Aug. 30, 2021 /PRNewswire/ --The Kaiser Permanente Bernard J. Tyson School of Medicine today announcedthe naming of Lori Carter-Edwards, PhD, MPH as Assistant Dean for Community Engagement.Dr.

Key Points: 
  • PASADENA, Calif., Aug. 30, 2021 /PRNewswire/ --The Kaiser Permanente Bernard J. Tyson School of Medicine today announcedthe naming of Lori Carter-Edwards, PhD, MPH as Assistant Dean for Community Engagement.Dr.
  • "Extending the reach of theschool into thecommunities we serve is integral to our mission and service-learning curriculum," said Maureen Connelly, MD, MPH, Senior Associate Dean for Academic and Community Affairs of the Kaiser Permanente Bernard J. Tyson School of Medicine.
  • "I am thrilled to join the Kaiser Permanente Bernard J. Tyson School of Medicine team.
  • About the Kaiser Permanente Bernard J. Tyson School of Medicine
    The Kaiser Permanente Bernard J. Tyson School of Medicine is devoted first and foremost to offering an outstanding, forward-thinking medical education.